Suppr超能文献

铁死亡在心血管疾病发生发展中的潜在病理机制。

The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease.

作者信息

Zhang Li-Li, Tang Rui-Jie, Yang Yue-Jin

机构信息

State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Cardiovasc Med. 2022 Aug 8;9:964034. doi: 10.3389/fcvm.2022.964034. eCollection 2022.

Abstract

Cardiovascular diseases (CVDs) have been attracting the attention of academic society for decades. Numerous researchers contributed to figuring out the core mechanisms underlying CVDs. Among those, pathological decompensated cellular loss posed by cell death in different kinds, namely necrosis, apoptosis and necroptosis, was widely regarded to accelerate the pathological development of most heart diseases and deteriorate cardiac function. Recently, apart from programmed cell death revealed previously, ferroptosis, a brand-new cellular death identified by its ferrous-iron-dependent manner, has been demonstrated to govern the occurrence and development of different cardiovascular disorders in many types of research as well. Therefore, clarifying the regulatory function of ferroptosis is conducive to finding out strategies for cardio-protection in different conditions and improving the prognosis of CVDs. Here, molecular mechanisms concerned are summarized systematically and categorized to depict the regulatory network of ferroptosis and point out potential therapeutic targets for diverse cardiovascular disorders.

摘要

几十年来,心血管疾病(CVDs)一直备受学术界关注。众多研究人员致力于弄清楚心血管疾病的核心机制。其中,由不同类型的细胞死亡,即坏死、凋亡和坏死性凋亡所导致的病理性失代偿性细胞丢失,被广泛认为会加速大多数心脏病的病理发展并使心脏功能恶化。最近,除了先前揭示的程序性细胞死亡外,铁死亡这种以铁离子依赖性方式识别的全新细胞死亡形式,在许多类型的研究中也已被证明与不同心血管疾病的发生和发展有关。因此,阐明铁死亡的调节功能有助于找到不同情况下的心脏保护策略并改善心血管疾病的预后。在此,对相关分子机制进行系统总结和分类,以描绘铁死亡的调节网络并指出针对各种心血管疾病的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68bf/9393259/5804acfed0f3/fcvm-09-964034-g001.jpg

相似文献

1
The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease.
Front Cardiovasc Med. 2022 Aug 8;9:964034. doi: 10.3389/fcvm.2022.964034. eCollection 2022.
2
Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases.
J Zhejiang Univ Sci B. 2024 Jan 15;25(1):1-22. doi: 10.1631/jzus.B2300097.
3
Emerging roles of ferroptosis in cardiovascular diseases.
Cell Death Discov. 2022 Sep 20;8(1):394. doi: 10.1038/s41420-022-01183-2.
4
The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine.
Front Pharmacol. 2023 Oct 26;14:1286718. doi: 10.3389/fphar.2023.1286718. eCollection 2023.
5
Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases.
Front Cardiovasc Med. 2022 Aug 4;9:909716. doi: 10.3389/fcvm.2022.909716. eCollection 2022.
6
Iron in Cardiovascular Disease: Challenges and Potentials.
Front Cardiovasc Med. 2021 Nov 30;8:707138. doi: 10.3389/fcvm.2021.707138. eCollection 2021.
7
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future.
Cell Biol Toxicol. 2024 Mar 21;40(1):17. doi: 10.1007/s10565-024-09853-w.
8
The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment.
Front Cardiovasc Med. 2021 Jul 22;8:710963. doi: 10.3389/fcvm.2021.710963. eCollection 2021.
9
Oxidative Stress-Induced Ferroptosis in Cardiovascular Diseases and Epigenetic Mechanisms.
Front Cell Dev Biol. 2021 Aug 19;9:685775. doi: 10.3389/fcell.2021.685775. eCollection 2021.
10
Ferroptosis and its emerging roles in cardiovascular diseases.
Pharmacol Res. 2021 Apr;166:105466. doi: 10.1016/j.phrs.2021.105466. Epub 2021 Feb 3.

引用本文的文献

1
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention.
Cancer Prev Res (Phila). 2025 Jun 2;18(6):321-334. doi: 10.1158/1940-6207.CAPR-24-0168.
2
MMP9 drives ferroptosis by regulating GPX4 and iron signaling.
iScience. 2024 Jul 30;27(9):110622. doi: 10.1016/j.isci.2024.110622. eCollection 2024 Sep 20.
3
Ovaries of estrogen receptor 1-deficient mice show iron overload and signs of aging.
Front Endocrinol (Lausanne). 2024 Feb 23;15:1325386. doi: 10.3389/fendo.2024.1325386. eCollection 2024.
4
Ferroptosis and its emerging role in kidney stone formation.
Mol Biol Rep. 2024 Feb 20;51(1):314. doi: 10.1007/s11033-024-09259-1.
5
Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies.
Mol Cell Biochem. 2024 Nov;479(11):2827-2841. doi: 10.1007/s11010-023-04895-w. Epub 2023 Dec 8.
6
The mechanism of ferroptosis and its related diseases.
Mol Biomed. 2023 Oct 16;4(1):33. doi: 10.1186/s43556-023-00142-2.

本文引用的文献

3
PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway.
Cell Death Differ. 2022 Oct;29(10):1982-1995. doi: 10.1038/s41418-022-00990-5. Epub 2022 Apr 5.
4
Chlorogenic Acid Alleviates Chronic Stress-Induced Duodenal Ferroptosis via the Inhibition of the IL-6/JAK2/STAT3 Signaling Pathway in Rats.
J Agric Food Chem. 2022 Apr 13;70(14):4353-4361. doi: 10.1021/acs.jafc.2c01196. Epub 2022 Apr 5.
5
[Ferroptosis in laryngeal squamous cell carcinoma and its regulation by M2 macrophage-derived exosomes].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Mar 7;57(3):324-332. doi: 10.3760/cma.j.cn115330-20210621-00361.
6
IL-6 protects cardiomyocytes from oxidative stress at the early stage of LPS-induced sepsis.
Biochem Biophys Res Commun. 2022 May 7;603:144-152. doi: 10.1016/j.bbrc.2022.03.013. Epub 2022 Mar 4.
8
Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells.
Cell Death Dis. 2022 Mar 7;13(3):212. doi: 10.1038/s41419-022-04660-9.
9
Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis.
Antioxidants (Basel). 2022 Jan 29;11(2):278. doi: 10.3390/antiox11020278.
10
Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling.
Free Radic Biol Med. 2022 Mar;181:130-142. doi: 10.1016/j.freeradbiomed.2022.01.020. Epub 2022 Feb 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验